Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026 Life Science Investing
Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares Life Science Investing
AbbVie Provides Update on TrenibotulinumtoxinE Biologics License Application in the U.S. Pharmaceutical Investing
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026 Medical Device Investing
Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex Life Science Investing
RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting Life Science Investing
